[S02DA03, antipyrine, The risk or severity of hypertension can be increased when Droperidol is combined with Antipyrine.]
[M03AB01, succinylcholine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Succinylcholine.]
[J01EC01, sulfamethoxazole, The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Droperidol.]
[S01AB02, sulfisoxazole, The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Droperidol.]
[M01AB02, sulindac, The risk or severity of hypertension can be increased when Droperidol is combined with Sulindac.]
[N05AL01, sulpiride, Droperidol may increase the antipsychotic activities of Sulpiride.]
[N03AX03, sulthiame, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Sulthiame.]
[M01AX04, apazone, The risk or severity of hypertension can be increased when Droperidol is combined with Azapropazone.]
[L02BA01, tamoxifen, The risk or severity of QTc prolongation can be increased when Tamoxifen is combined with Droperidol.]
[N05CD07, temazepam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Temazepam.]
[L01CB02, teniposide, Teniposide may increase the neurotoxic activities of Droperidol.]
[R03CC03, terbutaline, The therapeutic efficacy of Terbutaline can be decreased when used in combination with Droperidol.]
[N07XX06, tetrabenazine, The risk or severity of adverse effects can be increased when Droperidol is combined with Tetrabenazine.]
[S01HA03, tetracaine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tetracaine.]
[N05AE05, lurasidone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Lurasidone.]
[A04AD10, dronabinol, Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Droperidol.]
[N04BC07, apomorphine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Apomorphine.]
[L04AX02, thalidomide, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.]
[L01XX41, eribulin, The risk or severity of QTc prolongation can be increased when Eribulin is combined with Droperidol.]
[R06AD03, thiethylperazine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Thiethylperazine.]
[N05CA19, thiopental, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Thiopental.]
[N05AB08, thioproperazine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Thioproperazine.]
[N05AC02, thioridazine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Thioridazine.]
[N05AF04, thiothixene, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Thiothixene.]
[G04BE06, moxisylyte, The risk or severity of hypertension can be increased when Droperidol is combined with Moxisylyte.]
[N05AL03, tiapride, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tiapride.]
[N02AX01, tilidine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tilidine.]
[S01ED01, timolol, Timolol may increase the orthostatic hypotensive activities of Droperidol.]
[M02AX02, tolazoline, Droperidol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tolazoline.]
[M02AA21, tolmetin, The risk or severity of hypertension can be increased when Droperidol is combined with Tolmetin.]
[M03BX04, tolperisone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tolperisone.]
[N02AX02, tramadol, The risk or severity of CNS depression can be increased when Droperidol is combined with Tramadol.]
[N06AF04, tranylcypromine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tranylcypromine.]
[N06AX05, trazodone, The risk or severity of QTc prolongation can be increased when Trazodone is combined with Droperidol.]
[N05CD05, triazolam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Triazolam.]
[C03AA06, trichlormethiazide, Droperidol may decrease the antihypertensive activities of Trichlormethiazide.]
[A03AB12, mepenzolate, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Mepenzolate.]
[N05AB06, trifluoperazine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Trifluoperazine.]
[N05AD02, trifluperidol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Trifluperidol.]
[N05AA05, triflupromazine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Triflupromazine.]
[N04AA01, trihexyphenidyl, The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Droperidol.]
[A03AA05, trimebutine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Trimebutine.]
[R06AD01, trimeprazine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Alimemazine.]
[N03AC02, trimethadione, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Trimethadione.]
[C02BA01, trimethaphan, Droperidol may decrease the antihypertensive activities of Trimethaphan.]
[N06AA06, trimipramine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Trimipramine.]
[R06AX07, triprolidine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Triprolidine.]
[A03BB01, butylscopolamine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Butylscopolamine.]
[N06AX24, vilazodone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Vilazodone.]
[N06AX02, tryptophan, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tryptophan.]
[C09CA09, azilsartan medoxomil, Droperidol may decrease the antihypertensive activities of Azilsartan medoxomil.]
[M03AA02, tubocurarine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tubocurarine.]
[L01EX04, vandetanib, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Vandetanib.]
[J05AG05, rilpivirine, The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Droperidol.]
[N03AX21, ezogabine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ezogabine.]
[R03AC18, indacaterol, The therapeutic efficacy of Indacaterol can be decreased when used in combination with Droperidol.]
[C08DA01, verapamil, Droperidol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Verapamil.]
[N06AX09, viloxazine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.]
[C04AX07, vincamine, Droperidol may decrease the antihypertensive activities of Vincamine.]
[L01CA02, vincristine, Droperidol may increase the neurotoxic activities of Vincristine.]
[N01AX15, xenon, The risk or severity of hypertension can be increased when Droperidol is combined with Xenon.]
[C03BA10, xipamide, Droperidol may decrease the antihypertensive activities of Xipamide.]
[N05AF05, zuclopenthixol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Zuclopenthixol.]
[N03AX14, levetiracetam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Levetiracetam.]
[L01EC01, vemurafenib, The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Droperidol.]
[L01ED01, crizotinib, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Crizotinib.]
[M05BA06, ibandronic acid, The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Droperidol.]
[J01MA13, trovafloxacin, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Trovafloxacin.]
[N05AE04, ziprasidone, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Ziprasidone.]
[N02BA01, aspirin, The risk or severity of hypertension can be increased when Droperidol is combined with Acetylsalicylic acid.]
[G04BD07, tolterodine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.]
[C07AB03, atenolol, Atenolol may increase the orthostatic hypotensive activities of Droperidol.]
[J02AC03, voriconazole, The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Droperidol.]
[M03AC04, atracurium, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Atracurium.]
[S01FA01, atropine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Atropine.]
[G04BE10, avanafil, Droperidol may increase the hypotensive activities of Avanafil.]
[M03BX01, baclofen, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Droperidol.]
[A08AA11, lorcaserin, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Lorcaserin.]
[G04BD12, mirabegron, The therapeutic efficacy of Mirabegron can be decreased when used in combination with Droperidol.]
[C01CA18, octopamine, The therapeutic efficacy of Octopamine can be decreased when used in combination with Droperidol.]
[N05CA04, barbital, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Barbital.]
[J05AE04, nelfinavir, The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Droperidol.]
[S01GA07, brimonidine, Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Droperidol.]
[N04BD02, rasagiline, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.]
[C08CA13, lercanidipine, The risk or severity of hypotension can be increased when Droperidol is combined with Lercanidipine.]
[A03FA09, mosapride, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Mosapride.]
[N06DA02, donepezil, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Donepezil.]
[N03AX22, perampanel, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Perampanel.]
[N02CC03, zolmitriptan, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Zolmitriptan.]
[R06AC06, thonzylamine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Thonzylamine.]
[G04BD10, darifenacin, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.]
[N01AA01, ethyl ether, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Diethyl ether.]
[H01CB05, pasireotide, The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Droperidol.]
[G04BE03, sildenafil, The risk or severity of hypotension and syncope can be increased when Sildenafil is combined with Droperidol.]
[J04AK05, bedaquiline, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Bedaquiline.]
[C04AX11, bencyclane, The risk or severity of hypotension can be increased when Droperidol is combined with Bencyclane.]
[C03AA01, bendroflumethiazide, Droperidol may decrease the antihypertensive activities of Bendroflumethiazide.]
[L04AX06, pomalidomide, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pomalidomide.]
[N02BA10, benorilate, The risk or severity of hypertension can be increased when Droperidol is combined with Benorilate.]
[N05AD07, benperidol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Benperidol.]
[J01MA15, gemifloxacin, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Gemifloxacin.]
[S01AE07, moxifloxacin, The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Droperidol.]
[R02AD01, benzocaine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Benzocaine.]
[M01AH01, celecoxib, The risk or severity of hypertension can be increased when Droperidol is combined with Celecoxib.]
[N02CC02, naratriptan, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Naratriptan.]
[N04AC01, benztropine, The risk or severity of adverse effects can be increased when Droperidol is combined with Benzatropine.]
[L01EC02, dabrafenib, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Droperidol.]
[R02AX03, benzydamine, The risk or severity of hypertension can be increased when Droperidol is combined with Benzydamine.]
[P03AX06, benzyl alcohol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Benzyl alcohol.]
[N06AX28, levomilnacipran, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Levomilnacipran.]
[C08EA02, bepridil, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Bepridil.]
[C02KX05, riociguat, Droperidol may decrease the antihypertensive activities of Riociguat.]
[C02KX04, macitentan, Droperidol may decrease the antihypertensive activities of Macitentan.]
[N06AX26, vortioxetine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.]
[N03AF04, eslicarbazepine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Eslicarbazepine.]
[N03AG04, vigabatrin, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Vigabatrin.]
[C01CA27, droxidopa, The therapeutic efficacy of Droxidopa can be decreased when used in combination with Droperidol.]
[C07AB04, acebutolol, Acebutolol may increase the orthostatic hypotensive activities of Droperidol.]
[N05CH03, tasimelteon, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tasimelteon.]
[S01ED02, betaxolol, Betaxolol may increase the orthostatic hypotensive activities of Droperidol.]
[C02CC01, bethanidine, The therapeutic efficacy of Bethanidine can be decreased when used in combination with Droperidol.]
[L01ED02, ceritinib, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Ceritinib.]
[A03BA03, hyoscyamine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.]
[N01AX05, alfaxalone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Alfaxalone.]
[R03AC19, olodaterol, The therapeutic efficacy of Olodaterol can be decreased when used in combination with Droperidol.]
[D11AA01, glycopyrronium, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.]
[N05CM19, suvorexant, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A16AX10, eliglustat, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Eliglustat.]
[N05AA04, acepromazine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Acepromazine.]
[N04AA02, biperiden, The therapeutic efficacy of Biperiden can be decreased when used in combination with Droperidol.]
[N06AX11, mirtazapine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.]
[L01EX08, lenvatinib, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Lenvatinib.]
[L01XH03, panobinostat, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Panobinostat.]
[A03AA09, difemerine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Difemerine.]
[C01EB17, ivabradine, Ivabradine may increase the QTc-prolonging activities of Droperidol.]
[N05AX16, brexpiprazole, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Brexpiprazole.]
[G02CX02, flibanserin, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Flibanserin.]
[N05AX15, cariprazine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Cariprazine.]
[M02AA25, aceclofenac, The risk or severity of hypertension can be increased when Droperidol is combined with Aceclofenac.]
[M01AB11, acemetacin, The risk or severity of hypertension can be increased when Droperidol is combined with Acemetacin.]
[S01EC01, acetazolamide, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Acetazolamide.]
[N05AB07, acetophenazine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Acetophenazine.]
[B01AC27, selexipag, Droperidol may decrease the antihypertensive activities of Selexipag.]
[G04CA01, alfuzosin, Droperidol may increase the hypotensive activities of Alfuzosin.]
[N05CA05, aprobarbital, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Aprobarbital.]
[M01AE16, alminoprofen, The risk or severity of hypertension can be increased when Droperidol is combined with Alminoprofen.]
[N03AX23, brivaracetam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Brivaracetam.]
[N05BA08, bromazepam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Bromazepam.]
[N04BC01, bromocriptine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Bromocriptine.]
[A03AX08, alverine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Alverine.]
[R06AB01, brompheniramine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dexbrompheniramine.]
[N06AA19, amineptin, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Amineptine.]
[C08CA01, amlodipine, The risk or severity of hypotension can be increased when Droperidol is combined with Amlodipine.]
[N05AX17, pimavanserin, Droperidol may increase the neurotoxic activities of Pimavanserin.]
[N06BX11, aniracetam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Aniracetam.]
[N01BB01, bupivacaine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Bupivacaine.]
[C07AA19, bupranolol, Bupranolol may increase the orthostatic hypotensive activities of Droperidol.]
[N07BC01, buprenorphine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.]
[L02AE01, buserelin, The risk or severity of QTc prolongation can be increased when Buserelin is combined with Droperidol.]
[N05BE01, buspirone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Buspirone.]
[L01XX27, arsenic trioxide, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Arsenic trioxide.]
[P01BE02, artemether, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Artemether.]
[N02AF01, butorphanol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Butorphanol.]
[J01MA09, sparfloxacin, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Sparfloxacin.]
[R06AX09, azatadine, The risk or severity of QTc prolongation can be increased when Azatadine is combined with Droperidol.]
[S01GX07, azelastine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Azelastine.]
[S01AA26, azithromycin, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Droperidol.]
[L01EF02, ribociclib, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Ribociclib.]
[A07EC04, balsalazide, The risk or severity of hypertension can be increased when Droperidol is combined with Balsalazide.]
[R03CC12, bambuterol, The therapeutic efficacy of Bambuterol can be decreased when used in combination with Droperidol.]
[N07XX16, deutetrabenazine, The risk or severity of adverse effects can be increased when Droperidol is combined with Deutetrabenazine.]
[N02BF02, pregabalin, The therapeutic efficacy of Droperidol can be increased when used in combination with Pregabalin.]
[N03AX30, beclamide, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Beclamide.]
[C09AA07, benazepril, Droperidol may decrease the antihypertensive activities of Benazepril.]
[S01HA02, benoxinate, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Oxybuprocaine.]
[J01XX08, linezolid, The risk or severity of adverse effects can be increased when Linezolid is combined with Droperidol.]
[N04BD03, safinamide, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Safinamide.]
[J01MA23, delafloxacin, The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Droperidol.]
[L01XH01, vorinostat, The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Droperidol.]
[A02BX12, bismuth subnitrate, Droperidol may increase the neurotoxic activities of Bismuth subnitrate.]
[C07AB07, bisoprolol, Bisoprolol may increase the orthostatic hypotensive activities of Droperidol.]
[R03AC17, bitolterol, The therapeutic efficacy of Bitolterol can be decreased when used in combination with Droperidol.]
[J05AG03, efavirenz, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Efavirenz.]
[C07AA17, bopindolol, Bopindolol may increase the orthostatic hypotensive activities of Droperidol.]
[N04AA11, bornaprine, The therapeutic efficacy of Bornaprine can be decreased when used in combination with Droperidol.]
[N05AD06, bromperidol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Bromperidol.]
[N05CD09, brotizolam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Brotizolam.]
[N04BX03, budipine, The therapeutic efficacy of Budipine can be decreased when used in combination with Droperidol.]
[C04AX20, buflomedil, The risk or severity of hypertension can be increased when Droperidol is combined with Buflomedil.]
[M01AB07, bumadizone, The risk or severity of hypertension can be increased when Droperidol is combined with Bumadizone.]
[N05CA03, butobarbital, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Butobarbital.]
[N06AA15, butriptyline, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Butriptyline.]
[C01AA02, acetyldigoxins, The risk or severity of QTc prolongation can be increased when Acetyldigoxin is combined with Droperidol.]
[N05CA08, butylvinal, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Vinylbital.]
[R06AX18, acrivastine, The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Droperidol.]
[C09AA01, captopril, Droperidol may decrease the antihypertensive activities of Captopril.]
[V04CD06, macimorelin, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Macimorelin.]
[N03AF01, carbamazepine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.]
[A03AA03, camylofine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Camylofin.]
[R06AA08, carbinoxamine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Carbinoxamine.]
[C07AG02, carvedilol, Droperidol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Carvedilol.]
[B02BX09, fostamatinib, The risk or severity of hypotension and syncope can be increased when Fostamatinib is combined with Droperidol.]
[N03AX24, cannabidiol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Cannabidiol.]
[L01EC03, encorafenib, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Encorafenib.]
[C07AB08, celiprolol, The therapeutic efficacy of Celiprolol can be decreased when used in combination with Droperidol.]
[L01XX62, ivosidenib, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Ivosidenib.]
[N03AX17, stiripentol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Stiripentol.]
[S01GX12, cetirizine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Cetirizine.]
[N05CM04, carbromal, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Carbromal.]
[N01BA04, chloroprocaine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Chloroprocaine.]
[R06AA06, chlorphenoxamine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Chlorphenoxamine.]
[M01AC05, lornoxicam, The risk or severity of hypertension can be increased when Droperidol is combined with Lornoxicam.]
[N07XX15, inotersen, The risk or severity of QTc prolongation can be increased when Inotersen is combined with Droperidol.]
[M03BA02, carisoprodol, The risk or severity of adverse effects can be increased when Carisoprodol is combined with Droperidol.]
[R03BB08, revefenacin, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Revefenacin.]
[L01EX13, gilteritinib, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Gilteritinib.]
[L01XJ03, glasdegib, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Glasdegib.]
[N07XX05, amifampridine, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Amifampridine.]
[C01BG07, cifenline, The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Droperidol.]
[C09AA08, cilazapril, Droperidol may decrease the antihypertensive activities of Cilazapril.]
[B01AC23, cilostazol, The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Droperidol.]
[A03FA08, cinitapride, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Cinitapride.]
[P02BX04, triclabendazole, The risk or severity of QTc prolongation can be increased when Triclabendazole is combined with Droperidol.]
[N06AX27, esketamine, The risk or severity of hypertension can be increased when Esketamine is combined with Droperidol.]
[L04AA42, siponimod, The risk or severity of hypertension can be increased when Droperidol is combined with Siponimod.]
[J01FA09, clarithromycin, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Clarithromycin.]
[N06BA14, solriamfetol, The risk or severity of hypertension can be increased when Solriamfetol is combined with Droperidol.]
[N06AX29, brexanolone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Brexanolone.]
[N05BA09, clobazam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Clobazam.]
[N05BA22, cloxazolam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Cloxazolam.]
[C09CA06, candesartan, Droperidol may decrease the antihypertensive activities of Candesartan.]
[N05AA06, cyamemazine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Cyamemazine.]
[C03BX03, cicletanine, Droperidol may decrease the antihypertensive activities of Cicletanine.]
[M03BX08, cyclobenzaprine, The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Droperidol.]
[L01EX14, entrectinib, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Entrectinib.]
[N07XX11, pitolisant, Droperidol may increase the QTc-prolonging activities of Pitolisant.]
[J01XX12, lefamulin, Lefamulin may increase the QTc-prolonging activities of Droperidol.]
[N04CX01, istradefylline, The therapeutic efficacy of Istradefylline can be decreased when used in combination with Droperidol.]
[C03AA09, cyclothiazide, Droperidol may decrease the antihypertensive activities of Cyclothiazide.]
[G04BE04, yohimbine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Yohimbine.]
[N02CC08, lasmiditan, The risk or severity of adverse effects can be increased when Lasmiditan is combined with Droperidol.]
[R06AB06, dexbrompheniramine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dexbrompheniramine.]
[R06AB02, dexchlorpheniramine, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Dexchlorpheniramine.]
[N02AX03, dezocine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dezocine.]
[N05CM21, lemborexant, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Lemborexant.]
[N05AD10, lumateperone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Lumateperone.]
[S01AE06, gatifloxacin, The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Droperidol.]
[N02CC07, frovatriptan, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Frovatriptan.]
[G04CB02, dutasteride, The risk or severity of hypertension can be increased when Droperidol is combined with Dutasteride.]
[N05CC04, dichloralphenazone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dichloralphenazone.]
[A07DA04, difenoxin, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Difenoxin.]
[N02AA08, dihydrocodeine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dihydrocodeine.]
[N02CC06, eletriptan, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Eletriptan.]
[M01AH02, rofecoxib, The risk or severity of hypertension can be increased when Droperidol is combined with Rofecoxib.]
[C08CA16, clevidipine, The risk or severity of hypotension can be increased when Droperidol is combined with Clevidipine.]
[C01BD07, dronedarone, Droperidol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Dronedarone.]
[N03AG02, dipropylacetamide, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Valpromide.]
[R06AE04, chlorcyclizine, The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Droperidol.]
[N05BA02, chlordiazepoxide, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Chlordiazepoxide.]
[C02AA06, methoserpidine, Droperidol may decrease the antihypertensive activities of Methoserpidine.]
[A03AA08, dihexyverine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dihexyverine.]
[N04BX04, opicapone, The therapeutic efficacy of Opicapone can be decreased when used in combination with Droperidol.]
[C01CA14, dopexamine, The therapeutic efficacy of Dopexamine can be decreased when used in combination with Droperidol.]
[G04BD09, trospium, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Trospium.]
[M01AC04, droxicam, The risk or severity of hypertension can be increased when Droperidol is combined with Droxicam.]
[L01EX22, selpercatinib, The risk or severity of hypertension can be increased when Droperidol is combined with Selpercatinib.]
[M02AA27, dexketoprofen, The risk or severity of hypertension can be increased when Droperidol is combined with Dexketoprofen.]
[N05CM02, chlormethiazole, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Clomethiazole.]
[M03BB02, chlormezanone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Chlormezanone.]
[R02AD04, dyclonine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dyclonine.]
[C08CA17, levamlodipine, The risk or severity of hypotension can be increased when Droperidol is combined with Levamlodipine.]
[R06AX22, ebastine, The risk or severity of QTc prolongation can be increased when Ebastine is combined with Droperidol.]
[J05AX29, fostemsavir, The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Droperidol.]
[N05CD14, remimazolam, The risk or severity of sedation can be increased when Droperidol is combined with Remimazolam.]
[N02AX07, oliceridine, The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Droperidol is combined with Oliceridine.]
[P01BA01, chloroquine, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Chloroquine.]
[C03AA04, chlorothiazide, Droperidol may decrease the antihypertensive activities of Chlorothiazide.]
[R06AB04, chlorpheniramine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Chlorpheniramine.]
[N05AA01, chlorpromazine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Chlorpromazine.]
[N05AF03, chlorprothixene, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Chlorprothixene.]
[C03BA04, chlorthalidone, Droperidol may decrease the antihypertensive activities of Chlorthalidone.]
[M03BB03, chlorzoxazone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Chlorzoxazone.]
[N05BX03, etifoxine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Etifoxine.]
[N02BA07, ethenzamide, The risk or severity of hypertension can be increased when Droperidol is combined with Ethenzamide.]
[N06BX18, vinpocetine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Vinpocetine.]
[N05BA18, ethyl loflazepate, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ethyl loflazepate.]
[M01AB08, etodolac, The risk or severity of hypertension can be increased when Droperidol is combined with Etodolac.]
[M02AA06, etofenamate, The risk or severity of hypertension can be increased when Droperidol is combined with Etofenamate.]
[B06AC06, berotralstat, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Berotralstat.]
[L02BX04, relugolix, The risk or severity of QTc prolongation can be increased when Relugolix is combined with Droperidol.]
[L01FX21, naxitamab, The risk or severity of hypertension can be increased when Droperidol is combined with Naxitamab.]
[M03BA05, febarbamate, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Febarbamate.]
[N03AX10, felbamate, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Felbamate.]
[M01AE05, fenbufen, The risk or severity of hypertension can be increased when Droperidol is combined with Fenbufen.]
[C01CA19, fenoldopam, The therapeutic efficacy of Fenoldopam can be decreased when used in combination with Droperidol.]
[N06BA08, fenozolone, The risk or severity of hypertension can be increased when Droperidol is combined with Fenozolone.]
[G04CB01, finasteride, The risk or severity of hypertension can be increased when Droperidol is combined with Finasteride.]
[J01MB07, flumequine, The risk or severity of QTc prolongation can be increased when Flumequine is combined with Droperidol.]
[R03CC15, formoterol, The therapeutic efficacy of Formoterol can be decreased when used in combination with Droperidol.]
[L04AA50, ponesimod, The risk or severity of bradycardia can be increased when Ponesimod is combined with Droperidol.]
[N01AB05, trichloroethylene, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Trichloroethylene.]
[H04AA02, dasiglucagon, Droperidol may decrease the antihypertensive activities of Dasiglucagon.]
[N02BF01, gabapentin, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Gabapentin.]
[N07CA02, cinnarizine, The risk or severity of hypotension can be increased when Droperidol is combined with Cinnarizine.]
[J01MB06, cinoxacin, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Cinoxacin.]
[S03AA07, ciprofloxacin, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Ciprofloxacin.]
[N06AB04, citalopram, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Citalopram.]
[P01CA03, fexinidazole, The risk or severity of adverse effects can be increased when Droperidol is combined with Fexinidazole.]
[L01EB10, mobocertinib, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Mobocertinib.]
[R06AA04, clemastine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Clemastine.]
[R03CC13, clenbuterol, The therapeutic efficacy of Clenbuterol can be decreased when used in combination with Droperidol.]
[J01FF01, clindamycin, Droperidol may increase the neurotoxic activities of Clindamycin.]
[N06AX25, St. John's wort extract, Droperidol may increase the central nervous system depressant (CNS depressant) activities of St. John's Wort.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Droperidol.]
[J04BA01, clofazimine, The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Droperidol.]
[N01BB10, levobupivacaine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Levobupivacaine.]
[L01EJ03, pacritinib, The risk or severity of QTc prolongation can be increased when Pacritinib is combined with Droperidol.]
[N06AA04, clomipramine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Clomipramine.]
[N03AE01, clonazepam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Clonazepam.]
[S01EA04, clonidine, The risk or severity of sedation can be increased when Clonidine is combined with Droperidol.]
[N05AH06, clothiapine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Clothiapine.]
[N05BA21, clotiazepam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Clotiazepam.]
[A04AA01, ondansetron, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ondansetron.]
[A04AA02, granisetron, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Granisetron.]
[N05AH02, clozapine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Clozapine.]
[N05BA13, halazepam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Halazepam.]
[S02DA02, cocaine, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Cocaine.]
[C02KB01, metyrosine, The risk or severity of sedation and extrapyramidal symptoms can be increased when Metyrosine is combined with Droperidol.]
[M01AX13, proquazone, The risk or severity of hypertension can be increased when Droperidol is combined with Proquazone.]
[R05DA04, codeine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[M03AC05, hexafluorenium, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Hexafluronium.]
[A03AB10, hexocyclium, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Hexocyclium.]
[A03BB06, homatropine methylbromide, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Homatropine methylbromide.]
[N01AB07, desflurane, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Desflurane.]
[A04AA03, tropisetron, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tropisetron.]
[C04AX28, ifenprodil, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ifenprodil.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of hypertension can be increased when Droperidol is combined with Imidazole salicylate.]
[J01FA15, telithromycin, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Telithromycin.]
[B01AC10, indobufen, The risk or severity of hypertension can be increased when Droperidol is combined with Indobufen.]
[R06AX27, desloratadine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Desloratadine.]
[M01AH03, valdecoxib, The risk or severity of hypertension can be increased when Droperidol is combined with Valdecoxib.]
[A03AX10, isometheptene, The therapeutic efficacy of Isometheptene can be decreased when used in combination with Droperidol.]
[N02CC05, almotriptan, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Almotriptan.]
[M01AH04, parecoxib, The risk or severity of hypertension can be increased when Droperidol is combined with Parecoxib.]
[J02AC02, itraconazole, The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Droperidol.]
[S01GX06, emedastine, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Emedastine.]
[N05BA10, ketazolam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ketazolam.]
[M01AA06, kebuzone, The risk or severity of hypertension can be increased when Droperidol is combined with Kebuzone.]
[L01EA01, imatinib, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Imatinib.]
[J02AC04, posaconazole, The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Droperidol.]
[C08CA09, lacidipine, The risk or severity of hypotension can be increased when Droperidol is combined with Lacidipine.]
[N03AX09, lamotrigine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Lamotrigine.]
[S01GX02, levocabastine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Levocabastine.]
[N07BC04, lofexidine, The therapeutic efficacy of Droperidol can be increased when used in combination with Lofexidine.]
[S01AE04, lomefloxacin, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Lomefloxacin.]
[M01AB09, lonazolac, The risk or severity of hypertension can be increased when Droperidol is combined with Lonazolac.]
[N05CD06, lormetazepam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Lormetazepam.]
[M02AA31, loxoprofen, The risk or severity of hypertension can be increased when Droperidol is combined with Loxoprofen.]
[C09AA03, lisinopril, Droperidol may decrease the antihypertensive activities of Lisinopril.]
[C08CA11, manidipine, The risk or severity of hypotension can be increased when Droperidol is combined with Manidipine.]
[A03AA04, mebeverine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Mebeverine.]
[N06AX13, medifoxamine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Medifoxamine.]
[A08AA09, mefenorex, The risk or severity of hypertension can be increased when Droperidol is combined with Mefenorex.]
[C07AA14, mepindolol, Mepindolol may increase the orthostatic hypotensive activities of Droperidol.]
[R06AD07, mequitazine, Droperidol may increase the arrhythmogenic activities of Mequitazine.]
[C01EB10, adenosine, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Adenosine.]
[N04AA03, methixene, The therapeutic efficacy of Metixene can be decreased when used in combination with Droperidol.]
[C04AX01, cyclandelate, The risk or severity of hypotension can be increased when Droperidol is combined with Cyclandelate.]
[R03CB02, methoxyphenamine, The therapeutic efficacy of Droperidol can be decreased when used in combination with Methoxyphenamine.]
[R06AE03, cyclizine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Cyclizine.]
[N05CA10, cyclobarbital, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Cyclobarbital.]
[C03DA04, eplerenone, Droperidol may decrease the antihypertensive activities of Eplerenone.]
[N05AD03, metylperon, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Melperone.]
[C03AA07, cyclopenthiazide, Droperidol may decrease the antihypertensive activities of Cyclopenthiazide.]
[L01AA01, cyclophosphamide, Droperidol may increase the neurotoxic activities of Cyclophosphamide.]
[N06AX07, minaprine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Minaprine.]
[J04AB01, cycloserine, Cycloserine may increase the neurotoxic activities of Droperidol.]
[S01XA18, cyclosporine, The risk or severity of hypertension can be increased when Cyclosporine is combined with Droperidol.]
[N06AG02, moclobemide, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Moclobemide.]
[R06AX02, cyproheptadine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Cyproheptadine.]
[C09AA13, moexipril, Droperidol may decrease the antihypertensive activities of Moexipril.]
[M02AA02, mofebutazone, The risk or severity of hypertension can be increased when Droperidol is combined with Mofebutazone.]
[M01AX22, morniflumate, The risk or severity of hypertension can be increased when Droperidol is combined with Morniflumate.]
[C02AC05, moxonidine, The therapeutic efficacy of Moxonidine can be decreased when used in combination with Droperidol.]
[G04BE09, vardenafil, The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Droperidol.]
[M01AH05, etoricoxib, The risk or severity of hypertension can be increased when Droperidol is combined with Etoricoxib.]
[M03CA01, dantrolene, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dantrolene.]
[N06BX04, deanol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Deanol.]
[C02CC04, debrisoquin, Droperidol may decrease the antihypertensive activities of Debrisoquine.]
[A04AD11, nabilone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Nabilone.]
[M01AX01, nabumetone, The risk or severity of hypertension can be increased when Droperidol is combined with Nabumetone.]
[N05BA16, nordazepam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Nordazepam.]
[C07AB12, nebivolol, The therapeutic efficacy of Nebivolol can be decreased when used in combination with Droperidol.]
[N06AX06, nefazodone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Nefazodone.]
[N05CM16, niaprazine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Niaprazine.]
[C01DX16, nicorandil, Droperidol may decrease the antihypertensive activities of Nicorandil.]
[N03AG06, tiagabine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tiagabine.]
[C01CA23, theodrenaline, Droperidol may decrease the hypertensive activities of Theodrenaline.]
[M03AC11, cisatracurium, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Cisatracurium.]
[C01CA05, norfenefrine, The therapeutic efficacy of Norfenefrine can be decreased when used in combination with Droperidol.]
[R05DA06, normethadone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Normethadone.]
[N06AB10, escitalopram, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Escitalopram.]
[G04BD08, solifenacin, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.]
[A07EC03, olsalazine, The risk or severity of hypertension can be increased when Droperidol is combined with Olsalazine.]
[N06AA01, desipramine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Desipramine.]
[H01BA02, desmopressin, The risk or severity of hypertension can be increased when Desmopressin is combined with Droperidol.]
[C09XA02, aliskiren, Droperidol may decrease the antihypertensive activities of Aliskiren.]
[L01XA03, oxaliplatin, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Oxaliplatin.]
[M01AE12, oxaprozin, The risk or severity of hypertension can be increased when Droperidol is combined with Oxaprozin.]
[N03AF02, oxcarbazepine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Oxcarbazepine.]
[N06BX07, oxiracetam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Oxiracetam.]
[N04AA08, dexetimide, The therapeutic efficacy of Dexetimide can be decreased when used in combination with Droperidol.]
[G04BD04, oxybutynin, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.]
[A03AA01, oxyphencyclimine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Oxyphencyclimine.]
[N06BA02, dextroamphetamine, The therapeutic efficacy of Droperidol can be decreased when used in combination with Amphetamine.]
[R05DA09, dextromethorphan, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dextromethorphan.]
[N03AC01, paramethadione, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Paramethadione.]
[N02AC01, dextromoramide, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dextromoramide.]
[N06AB05, paroxetine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Paroxetine.]
[N07BC06, heroin, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Diamorphine.]
[N05BA01, diazepam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Diazepam.]
[N03AX07, phenacemide, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Phenacemide.]
[V03AH01, diazoxide, Droperidol may decrease the antihypertensive activities of Diazoxide.]
[N03AD02, phensuximide, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Phensuximide.]
[N06AA08, dibenzepin, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dibenzepin.]
[S02DA04, dibucaine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Cinchocaine.]
[S01BC03, diclofenac, The risk or severity of hypertension can be increased when Droperidol is combined with Diclofenac.]
[J05AD01, foscarnet, The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Droperidol.]
[A03AA07, dicyclomine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.]
[J05AF02, didanosine, Droperidol may increase the neurotoxic activities of Didanosine.]
[C02DG01, pinacidil, Droperidol may decrease the antihypertensive activities of Pinacidil.]
[A03AX04, pinaverium, The risk or severity of hypotension can be increased when Droperidol is combined with Pinaverium.]
[N05AD05, pipamperone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pipamperone.]
[A03AB14, pipenzolate, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pipenzolate.]
[L01EB02, erlotinib, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Erlotinib.]
[R03CC07, pirbuterol, The therapeutic efficacy of Pirbuterol can be decreased when used in combination with Droperidol.]
[A08AA03, diethylpropion, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Diethylpropion.]
[C08CA03, isradipine, The risk or severity of hypotension can be increased when Droperidol is combined with Isradipine.]
[A03AB11, poldine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Poldine.]
[N02BA11, diflunisal, The risk or severity of hypertension can be increased when Droperidol is combined with Diflunisal.]
[C01AA04, digitoxin, The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Droperidol.]
[C01AA05, digoxin, The risk or severity of QTc prolongation can be increased when Digoxin is combined with Droperidol.]
[C02DB01, dihydralazine, Droperidol may decrease the antihypertensive activities of Dihydralazine.]
[C04AE04, dihydroergocristine, The risk or severity of hypertension can be increased when Droperidol is combined with Dihydroergocristine.]
[N02CA01, dihydroergotamine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dihydroergotamine.]
[N02AA03, hydromorphone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Hydromorphone.]
[J05AE08, atazanavir, The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Droperidol.]
[B01AC21, treprostinil, Droperidol may decrease the antihypertensive activities of Treprostinil.]
[D04AB07, pramoxine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pramocaine.]
[C08DB01, diltiazem, The risk or severity of hypotension can be increased when Droperidol is combined with Diltiazem.]
[R06AA11, dimenhydrinate, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dimenhydrinate.]
[M03BX03, pridinol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pridinol.]
[R06AB03, dimethindene, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dimetindene.]
[R03CC08, procaterol, The therapeutic efficacy of Procaterol can be decreased when used in combination with Droperidol.]
[N03AG05, progabide, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Progabide.]
[N02BB04, propyphenazone, The risk or severity of hypertension can be increased when Droperidol is combined with Propyphenazone.]
[M01AB14, proglumetacin, The risk or severity of hypertension can be increased when Droperidol is combined with Proglumetacin.]
[R06AA02, diphenhydramine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Diphenhydramine.]
[A07DA01, diphenoxylate, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Diphenoxylate.]
[N05CD10, quazepam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Quazepam.]
[C09AA06, quinapril, Droperidol may decrease the antihypertensive activities of Quinapril.]
[B01AC07, dipyridamole, The risk or severity of hypotension and syncope can be increased when Dipyridamole is combined with Droperidol.]
[N06BA11, dexmethylphenidate, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dexmethylphenidate.]
[N06AA23, quinupramine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Quinupramine.]
[A03FA02, cisapride, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Cisapride.]
[C09AA05, ramipril, Droperidol may decrease the antihypertensive activities of Ramipril.]
[N05AL04, remoxipride, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Remoxipride.]
[R03CC14, reproterol, The therapeutic efficacy of Reproterol can be decreased when used in combination with Droperidol.]
[C01BA03, disopyramide, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Disopyramide.]
[P03AA04, disulfiram, The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Droperidol.]
[N07XX02, riluzole, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Riluzole.]
[N05AX08, risperidone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Risperidone.]
[R06AE09, levocetirizine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Levocetirizine.]
[N01BB09, ropivacaine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ropivacaine.]
[J01MB01, rosoxacin, The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Droperidol.]
[L01EX01, sunitinib, The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Droperidol.]
[L01XG01, bortezomib, The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Droperidol.]
[G04BE08, tadalafil, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Droperidol.]
[S01BC05, ketorolac, The risk or severity of hypertension can be increased when Droperidol is combined with Ketorolac.]
[C02KX02, ambrisentan, Droperidol may decrease the antihypertensive activities of Ambrisentan.]
[C01EB18, ranolazine, The risk or severity of QTc prolongation can be increased when Ranolazine is combined with Droperidol.]
[N02BA06, salsalate, The risk or severity of hypertension can be increased when Droperidol is combined with Salsalate.]
[R03AC12, salmeterol, The therapeutic efficacy of Salmeterol can be decreased when used in combination with Droperidol.]
[C01CA07, dobutamine, The therapeutic efficacy of Dobutamine can be decreased when used in combination with Droperidol.]
[A03FA03, domperidone, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Domperidone.]
[C01CA04, dopamine, The risk or severity of hypertension can be increased when Droperidol is combined with Dopamine.]
[N06AA16, dothiepin, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dosulepin.]
[R07AB01, doxapram, The risk or severity of hypertension can be increased when Droperidol is combined with Doxapram.]
[N06AA12, doxepin, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Doxepin.]
[R06AA09, doxylamine, Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Droperidol.]
[N06AB06, sertraline, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Sertraline.]
[N01AB08, sevoflurane, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Sevoflurane.]
[J01MB04, pipemidic acid, The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Droperidol.]
[N07XX04, sodium oxybate, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.]
[M01AG01, mefenamic acid, The risk or severity of hypertension can be increased when Droperidol is combined with Mefenamic acid.]
[A08AA10, sibutramine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Sibutramine.]
[C09AA11, spirapril, Droperidol may decrease the antihypertensive activities of Spirapril.]
[N05AL02, sultopride, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Sultopride.]
[N02CC01, sumatriptan, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Sumatriptan.]
[C07AB13, talinolol, Talinolol may increase the orthostatic hypotensive activities of Droperidol.]
[J01MA05, temafloxacin, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Temafloxacin.]
[M01AC02, tenoxicam, The risk or severity of hypertension can be increased when Droperidol is combined with Tenoxicam.]
[G04CA03, terazosin, Droperidol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Terazosin.]
[G04BD05, terodiline, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Terodiline.]
[C07AA16, tertatolol, Tertatolol may increase the orthostatic hypotensive activities of Droperidol.]
[S01GA02, tetrahydrozoline, The therapeutic efficacy of Tetryzoline can be decreased when used in combination with Droperidol.]
[M03BX07, tetrazepam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tetrazepam.]
[M03BX05, thiocolchicoside, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Thiocolchicoside.]
[N05AB05, thiopropazate, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Thiopropazate.]
[G04BD01, emepronium, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Emepronium.]
[N06AX14, tianeptine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tianeptine.]
[C09AA02, enalapril, Droperidol may decrease the antihypertensive activities of Enalapril.]
[N05BA23, tofisopam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tofisopam.]
[M01AG02, tolfenamic acid, The risk or severity of hypertension can be increased when Droperidol is combined with Tolfenamic acid.]
[N06AG03, toloxatone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Toloxatone.]
[N06BA09, atomoxetine, The risk or severity of hypertension can be increased when Atomoxetine is combined with Droperidol.]
[N03AX11, topiramate, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Topiramate.]
[L02BA02, toremifene, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Toremifene.]
[C03CA04, torsemide, Droperidol may decrease the antihypertensive activities of Torasemide.]
[R01AA09, tramazoline, The risk or severity of hypertension can be increased when Droperidol is combined with Tramazoline.]
[C09AA10, trandolapril, Droperidol may decrease the antihypertensive activities of Trandolapril.]
[N05CD11, triazulenone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Loprazolam.]
[N05CM07, triclofos, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Triclofos.]
[A03AB08, tridihexethyl, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tridihexethyl.]
[R06AA10, trimethobenzamide, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Trimethobenzamide.]
[L02AE04, triptorelin, The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Droperidol.]
[N04AA12, tropatepine, The therapeutic efficacy of Tropatepine can be decreased when used in combination with Droperidol.]
[R03CC11, tulobuterol, The therapeutic efficacy of Tulobuterol can be decreased when used in combination with Droperidol.]
[N01AB04, enflurane, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Enflurane.]
[C02CA06, urapidil, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Urapidil.]
[J01MA04, enoxacin, The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Droperidol.]
[N05AL06, veralipride, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Veralipride.]
[L01CA04, vinorelbine, Vinorelbine may increase the neurotoxic activities of Droperidol.]
[S01FB02, ephedrine, The therapeutic efficacy of Ephedrine can be decreased when used in combination with Droperidol.]
[S01GX10, epinastine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Epinastine.]
[N06AX16, venlafaxine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine.]
[C01CX07, xamoterol, The therapeutic efficacy of Xamoterol can be decreased when used in combination with Droperidol.]
[S01GA03, xylometazoline, The therapeutic efficacy of Xylometazoline can be decreased when used in combination with Droperidol.]
[C08CA12, mepirodipine, The risk or severity of hypotension can be increased when Droperidol is combined with Barnidipine.]
[S01EA01, epinephrine, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Droperidol.]
[C09AA15, zofenopril, Droperidol may decrease the antihypertensive activities of Zofenopril.]
[N05CF02, zolpidem, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.]
[M01AB04, zomepirac, The risk or severity of hypertension can be increased when Droperidol is combined with Zomepirac.]
[N03AX15, zonisamide, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Zonisamide.]
[N05CF01, zopiclone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Zopiclone.]
[N05AX11, zotepine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Zotepine.]
[C02AC02, guanfacine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Guanfacine.]
[C01BG01, moricizine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Moricizine.]
[G02AB03, ergonovine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ergometrine.]
[C04AE01, ergoloid mesylates, USP, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ergoloid mesylate.]
[N02CA02, ergotamine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ergotamine.]
[S01AA17, erythromycin, The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Droperidol.]
[N05CD04, estazolam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Estazolam.]
[C01CA15, gepefrine, The therapeutic efficacy of Droperidol can be decreased when used in combination with Gepefrine.]
[N05CM08, ethchlorvynol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ethchlorvynol.]
[C01BD05, ibutilide, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Ibutilide.]
[N04AA05, profenamine, The therapeutic efficacy of Profenamine can be decreased when used in combination with Droperidol.]
[N03AD01, ethosuximide, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ethosuximide.]
[N03AB01, ethotoin, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ethotoin.]
[M01AC06, meloxicam, The risk or severity of hypertension can be increased when Droperidol is combined with Meloxicam.]
[S01XA06, ethylmorphine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ethylmorphine.]
[C01CA01, etilefrine, The therapeutic efficacy of Etilefrine can be decreased when used in combination with Droperidol.]
[N01AX07, etomidate, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Etomidate.]
[N05AE03, sertindole, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Sertindole.]
[C01BA05, ajmaline, The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Droperidol.]
[L04AD02, tacrolimus, The risk or severity of QTc prolongation can be increased when Tacrolimus is combined with Droperidol.]
[J01MA08, fleroxacin, The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Droperidol.]
[R06AX11, astemizole, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Astemizole.]
[R06AX12, terfenadine, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Terfenadine.]
[N06AX12, bupropion, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Bupropion.]
[N06AB08, fluvoxamine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Fluvoxamine.]
[C01BC08, encainide, The risk or severity of QTc prolongation can be increased when Encainide is combined with Droperidol.]
[L02AE02, leuprolide, The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Droperidol.]
[A02BA03, famotidine, The risk or severity of QTc prolongation can be increased when Famotidine is combined with Droperidol.]
[C08CA02, felodipine, The risk or severity of hypotension can be increased when Droperidol is combined with Felodipine.]
[C08EA01, fendiline, The risk or severity of hypotension can be increased when Droperidol is combined with Fendiline.]
[N03AX26, fenfluramine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Fenfluramine.]
[M01AE04, fenoprofen, The risk or severity of hypertension can be increased when Droperidol is combined with Fenoprofen.]
[R03CC04, fenoterol, The therapeutic efficacy of Fenoterol can be decreased when used in combination with Droperidol.]
[R03CC02, albuterol, The therapeutic efficacy of Salbutamol can be decreased when used in combination with Droperidol.]
[G04BD02, flavoxate, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.]
[C01BC04, flecainide, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Flecainide.]
[N02BG04, floctafenine, The risk or severity of hypertension can be increased when Droperidol is combined with Floctafenine.]
[J02AC01, fluconazole, The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Droperidol.]
[N07CA03, flunarizine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Flunarizine.]
[N05CD03, flunitrazepam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Flunitrazepam.]
[N06AA14, melitracen, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Melitracen.]
[V03AZ01, ethanol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ethanol.]
[L01BC02, fluorouracil, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Fluorouracil.]
[N06AB03, fluoxetine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.]
[N05AF01, flupenthixol, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Flupentixol.]
[N05AB02, fluphenazine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Fluphenazine.]
[N05CD01, flurazepam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Flurazepam.]
[S01BC04, flurbiprofen, The risk or severity of hypertension can be increased when Droperidol is combined with Flurbiprofen.]
[N05AG01, fluspirilene, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Fluspirilene.]
[N06BX17, adrafinil, The therapeutic efficacy of Adrafinil can be decreased when used in combination with Droperidol.]
[M03AA01, alcuronium, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Alcuronium.]
[G01AX06, furazolidone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Furazolidone.]
[C03CA01, furosemide, Droperidol may decrease the antihypertensive activities of Furosemide.]
[N05CF04, eszopiclone, The risk or severity of CNS depression can be increased when Droperidol is combined with Eszopiclone.]
[N05AL05, amisulpride, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Amisulpride.]
[N06DA04, galantamine, The risk or severity of QTc prolongation can be increased when Galantamine is combined with Droperidol.]
[M03AC02, gallamine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Gallamine.]
[C08DA02, gallopamil, The risk or severity of hypotension can be increased when Droperidol is combined with Gallopamil.]
[N03AA04, barbexaclone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Barbexaclone.]
[N06AX08, bifemelane, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Bifemelane.]
[J01XA03, telavancin, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Telavancin.]
[L02BX02, degarelix, The risk or severity of QTc prolongation can be increased when Degarelix is combined with Droperidol.]
[L01EA02, dasatinib, The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Droperidol.]
[N04BC06, cabergoline, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Cabergoline.]
[N03AD03, methsuximide, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Methsuximide.]
[N01AH02, alfentanil, The risk or severity of hypertension can be increased when Alfentanil is combined with Droperidol.]
[L01EH01, lapatinib, The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Droperidol.]
[N05CM18, dexmedetomidine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dexmedetomidine.]
[N05CE01, glutethimide, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Glutethimide.]
[C05AE01, nitroglycerin, Droperidol may decrease the antihypertensive activities of Nitroglycerin.]
[C01BD04, dofetilide, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Dofetilide.]
[C02CA04, doxazosin, Droperidol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Doxazosin.]
[L01EX02, sorafenib, The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Droperidol.]
[C07AB09, esmolol, Esmolol may increase the orthostatic hypotensive activities of Droperidol.]
[C09AA09, fosinopril, Droperidol may decrease the antihypertensive activities of Fosinopril.]
[S01EX01, guanethidine, Droperidol may decrease the antihypertensive activities of Guanethidine.]
[L02AE03, goserelin, The risk or severity of QTc prolongation can be increased when Goserelin is combined with Droperidol.]
[P01BX01, halofantrine, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Halofantrine.]
[N05AD01, haloperidol, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Haloperidol.]
[N01AB01, halothane, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Halothane.]
[L02AE05, histrelin, The risk or severity of QTc prolongation can be increased when Histrelin is combined with Droperidol.]
[N05AH04, quetiapine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.]
[N02CX03, iprazochrome, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Iprazochrome.]
[N05CA21, allobarbital, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Allobarbital.]
[C09CA01, losartan, Droperidol may decrease the antihypertensive activities of Losartan.]
[A07EC02, mesalamine, The risk or severity of hypertension can be increased when Mesalazine is combined with Droperidol.]
[N05CA16, hexobarbital, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Hexobarbital.]
[R03CC05, hexoprenaline, The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Droperidol.]
[C08CA10, nilvadipine, The risk or severity of hypotension can be increased when Droperidol is combined with Nilvadipine.]
[M02AA26, nimesulide, The risk or severity of hypotension can be increased when Droperidol is combined with Nimesulide.]
[R06AE06, oxatomide, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Oxatomide.]
[C09AA04, perindopril, Droperidol may decrease the antihypertensive activities of Perindopril.]
[C02DB02, hydralazine, Droperidol may decrease the antihypertensive activities of Hydralazine.]
[C03AA03, hydrochlorothiazide, Droperidol may decrease the antihypertensive activities of Hydrochlorothiazide.]
[R05DA03, hydrocodone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.]
[C03AA02, hydroflumethiazide, Droperidol may decrease the antihypertensive activities of Hydroflumethiazide.]
[G04BD06, propiverine, Droperidol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Propiverine.]
[P01BA02, hydroxychloroquine, The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Droperidol.]
[N05AX07, prothipendyl, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Prothipendyl.]
[N05BB01, hydroxyzine, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Hydroxyzine.]
[C02AC06, rilmenidine, The therapeutic efficacy of Rilmenidine can be decreased when used in combination with Droperidol.]
[R02AX02, ibuprofen, The risk or severity of hypertension can be increased when Droperidol is combined with Ibuprofen.]
[B05CB02, sodium citrate, Droperidol may increase the neurotoxic activities of Sodium citrate.]
[N01AH03, sufentanil, The risk or severity of hypertension can be increased when Sufentanil is combined with Droperidol.]
[N06AA02, imipramine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Imipramine.]
[L01CD01, paclitaxel, Droperidol may increase the neurotoxic activities of Paclitaxel.]
[H01BA04, terlipressin, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Terlipressin.]
[M03BX02, tizanidine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tizanidine.]
[C03BA11, indapamide, Droperidol may decrease the antihypertensive activities of Indapamide.]
[S01BC01, indomethacin, The risk or severity of hypertension can be increased when Indomethacin is combined with Droperidol.]
[C02CA02, indoramin, Droperidol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Indoramin.]
[N06AX17, milnacipran, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Milnacipran.]
[A03AA30, piperidolate, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Piperidolate.]
[N01BB08, articaine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Articaine.]
[N05BA12, alprazolam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Alprazolam.]
[N05CH02, ramelteon, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ramelteon.]
[R06AE01, buclizine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Buclizine.]
[L01XX35, anagrelide, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Anagrelide.]
[C07AA01, alprenolol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Alprenolol.]
[J05AF04, stavudine, Droperidol may increase the neurotoxic activities of Stavudine.]
[N06AA13, iprindole, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Iprindole.]
[N06AF05, iproniazid, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Iproniazid.]
[N05AA07, chlorproethazine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Chlorproethazine.]
[N06AF01, isocarboxazid, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Isocarboxazid.]
[R03CC06, isoetharine, The therapeutic efficacy of Isoetharine can be decreased when used in combination with Droperidol.]
[C09AA16, imidapril, Droperidol may decrease the antihypertensive activities of Imidapril.]
[N01AB06, isoflurane, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Isoflurane.]
[N04BX02, entacapone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Entacapone.]
[R03CB01, isoproterenol, The therapeutic efficacy of Isoprenaline can be decreased when used in combination with Droperidol.]
[C04AA01, isoxsuprine, The therapeutic efficacy of Isoxsuprine can be decreased when used in combination with Droperidol.]
[N06AX18, reboxetine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Reboxetine.]
[N01AX03, ketamine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ketamine.]
[C02KD01, ketanserin, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ketanserin.]
[J02AB02, ketoconazole, The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Droperidol.]
[N05AH03, olanzapine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Olanzapine.]
[M02AA10, ketoprofen, The risk or severity of hypertension can be increased when Droperidol is combined with Ketoprofen.]
[R06AX25, mizolastine, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Mizolastine.]
[C01CA22, arbutamine, The therapeutic efficacy of Arbutamine can be decreased when used in combination with Droperidol.]
[N04BC09, rotigotine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Rotigotine.]
[J01MB02, nalidixic acid, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Nalidixic acid.]
[M01AE11, tiaprofenic acid, The risk or severity of hypertension can be increased when Droperidol is combined with Tiaprofenic acid.]
[C07AG01, labetalol, Droperidol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Labetalol.]
[N04BB01, amantadine, The therapeutic efficacy of Amantadine can be decreased when used in combination with Droperidol.]
[C02AA05, deserpidine, Droperidol may decrease the antihypertensive activities of Deserpidine.]
[N03AX18, lacosamide, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Lacosamide.]
[N04BA01, levodopa, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Levodopa.]
[S02DA01, lidocaine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Lidocaine.]
[C08EX01, lidoflazine, The risk or severity of hypotension can be increased when Droperidol is combined with Lidoflazine.]
[J01FF02, lincomycin, Droperidol may increase the neurotoxic activities of Lincomycin.]
[N02CA07, lisuride, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Lisuride.]
[N06AA07, lofepramine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Lofepramine.]
[A07DA03, loperamide, The risk or severity of hypotension can be increased when Droperidol is combined with Loperamide.]
[N05BA06, lorazepam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Lorazepam.]
[N05AH01, loxapine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Loxapine.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Droperidol can be increased when used in combination with Magnesium sulfate.]
[L01EA03, nilotinib, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Nilotinib.]
[N06AA21, maprotiline, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Maprotiline.]
[A08AA05, mazindol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Mazindol.]
[C02BB01, mecamylamine, Droperidol may decrease the antihypertensive activities of Mecamylamine.]
[R06AE05, meclizine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Meclizine.]
[M02AA18, meclofenamic acid, The risk or severity of hypertension can be increased when Droperidol is combined with Meclofenamic acid.]
[N05BA03, medazepam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Medazepam.]
[P01BC02, mefloquine, The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Droperidol.]
[N05CH01, melatonin, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Melatonin.]
[N06DX01, memantine, The therapeutic efficacy of Memantine can be decreased when used in combination with Droperidol.]
[N02AB02, meperidine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Meperidine.]
[C01CA11, mephentermine, The therapeutic efficacy of Droperidol can be decreased when used in combination with Mephentermine.]
[N03AB04, mephenytoin, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Mephenytoin.]
[N03AA01, mephobarbital, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Methylphenobarbital.]
[N01BB03, mepivacaine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Mepivacaine.]
[N05BC01, meprobamate, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Meprobamate.]
[N02AX05, meptazinol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Meptazinol.]
[N05AC03, mesoridazine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Mesoridazine.]
[N05AX13, paliperidone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Paliperidone.]
[C01CA09, metaraminol, The therapeutic efficacy of Metaraminol can be decreased when used in combination with Droperidol.]
[A04AA04, dolasetron, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dolasetron.]
[N07BC02, methadone, The risk or severity of adverse effects can be increased when Methadone is combined with Droperidol.]
[N06BA03, methamphetamine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Metamfetamine.]
[A03AB07, methantheline, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Methantheline.]
[R06AC05, methapyrilene, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Methapyrilene.]
[N05CM01, methaqualone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Methaqualone.]
[N03AA30, metharbital, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Metharbital.]
[G02CB05, metergoline, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Metergoline.]
[M03BA03, methocarbamol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Methocarbamol.]
[N05CA15, methohexital, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Methohexital.]
[N02BG08, ziconotide, The risk or severity of CNS depression can be increased when Droperidol is combined with Ziconotide.]
[L04AX03, methotrexate, The excretion of Methotrexate can be decreased when combined with Droperidol.]
[N05AA02, methotrimeprazine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.]
[C01CA10, methoxamine, The therapeutic efficacy of Methoxamine can be decreased when used in combination with Droperidol.]
[N02BG09, methoxyflurane, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Methoxyflurane.]
[C02AB01, methyldopa, The therapeutic efficacy of Methyldopa can be decreased when used in combination with Droperidol.]
[V04CG05, methylene blue, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Methylene blue.]
[G02AB01, methylergonovine, The risk or severity of hypertension can be increased when Methylergometrine is combined with Droperidol.]
[N06BA04, methylphenidate, The risk or severity of adverse effects can be increased when Droperidol is combined with Methylphenidate.]
[N03AF03, rufinamide, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Rufinamide.]
[N05CE02, methyprylon, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Methyprylon.]
[N02CA04, methysergide, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Methysergide.]
[A03FA01, metoclopramide, The risk or severity of adverse effects can be increased when Droperidol is combined with Metoclopramide.]
[C03BA08, metolazone, Droperidol may decrease the antihypertensive activities of Metolazone.]
[C07AB02, metoprolol, Metoprolol may increase the orthostatic hypotensive activities of Droperidol.]
[P01AB01, metronidazole, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Droperidol.]
[N06AX03, mianserin, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Mianserin.]
[N02BB03, aminopyrine, The risk or severity of hypertension can be increased when Droperidol is combined with Aminophenazone.]
[N05CD08, midazolam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Midazolam.]
[C01CA17, midodrine, The therapeutic efficacy of Midodrine can be decreased when used in combination with Droperidol.]
[G03XB01, mifepristone, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Mifepristone.]
[C09CA03, valsartan, Droperidol may decrease the antihypertensive activities of Valsartan.]
[J01AA08, minocycline, Minocycline may increase the central nervous system depressant (CNS depressant) activities of Droperidol.]
[D11AX01, minoxidil, Droperidol may decrease the antihypertensive activities of Minoxidil.]
[N06BA12, lisdexamfetamine, The therapeutic efficacy of Droperidol can be decreased when used in combination with Lisdexamfetamine.]
[N05AE02, molindone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Molindone.]
[C01BD01, amiodarone, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Amiodarone.]
[N06AA09, amitriptyline, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.]
[N02AA01, morphine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Morphine.]
[A04AA05, palonosetron, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Palonosetron.]
[L01EX03, pazopanib, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Pazopanib.]
[M03AC03, vecuronium, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Vecuronium.]
[N05CA02, amobarbital, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Amobarbital.]
[P01BA06, amodiaquine, The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Droperidol.]
[G04CA04, silodosin, Droperidol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Silodosin.]
[N06AA17, amoxapine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.]
[N03AB05, fosphenytoin, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Fosphenytoin.]
[C07AA12, nadolol, Nadolol may increase the orthostatic hypotensive activities of Droperidol.]
[N04BC04, ropinirole, The therapeutic efficacy of Ropinirole can be decreased when used in combination with Droperidol.]
[C04AX21, nafronyl, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Naftidrofuryl.]
[N02AF02, nalbuphine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Nalbuphine.]
[S01GA01, naphazoline, The therapeutic efficacy of Naphazoline can be decreased when used in combination with Droperidol.]
[N06BA01, amphetamine, The therapeutic efficacy of Droperidol can be decreased when used in combination with Amphetamine.]
[M02AA12, naproxen, The risk or severity of hypertension can be increased when Droperidol is combined with Naproxen.]
[N06AX21, duloxetine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Duloxetine.]
[N04BX01, tolcapone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tolcapone.]
[S03AA01, neomycin, Droperidol may increase the neurotoxic activities of Neomycin.]
[N01AH06, remifentanil, The risk or severity of hypertension can be increased when Remifentanil is combined with Droperidol.]
[C01CX08, levosimendan, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Levosimendan.]
[N05AX14, iloperidone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Iloperidone.]
[N06AX23, desvenlafaxine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Desvenlafaxine.]
[C09CA07, telmisartan, Droperidol may decrease the antihypertensive activities of Telmisartan.]
[N06AF02, nialamide, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Nialamide.]
[C08CA04, nicardipine, Droperidol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Nicardipine.]
[C04AE02, nicergoline, Droperidol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Nicergoline.]
[C08CA05, nifedipine, The risk or severity of hypotension can be increased when Droperidol is combined with Nifedipine.]
[M02AA17, niflumic acid, The risk or severity of hypertension can be increased when Droperidol is combined with Niflumic acid.]
[C08CA06, nimodipine, The risk or severity of hypotension can be increased when Droperidol is combined with Nimodipine.]
[C08CA07, nisoldipine, The risk or severity of hypotension can be increased when Droperidol is combined with Nisoldipine.]
[N05CD02, nitrazepam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Nitrazepam.]
[C08CA08, nitrendipine, The risk or severity of hypotension can be increased when Droperidol is combined with Nitrendipine.]
[N05CF03, zaleplon, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Zaleplon.]
[N04BC05, pramipexole, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Droperidol.]
[C02DD01, nitroprusside, Droperidol may decrease the antihypertensive activities of Nitroprusside.]
[N01AX13, nitrous oxide, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Nitrous oxide.]
[N06AX04, nomifensine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Nomifensine.]
[C01CA03, norepinephrine, The therapeutic efficacy of Norepinephrine can be decreased when used in combination with Droperidol.]
[S01AE02, norfloxacin, The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Droperidol.]
[C02KX01, bosentan, Droperidol may decrease the antihypertensive activities of Bosentan.]
[N06AA10, nortriptyline, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Nortriptyline.]
[G02CA02, nylidrin, The therapeutic efficacy of Nylidrin can be decreased when used in combination with Droperidol.]
[H01CB02, octreotide, The risk or severity of QTc prolongation can be increased when Octreotide is combined with Droperidol.]
[S02AA16, ofloxacin, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Ofloxacin.]
[N06AA05, opipramol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Opipramol.]
[N02AA02, opium, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Opium.]
[R03CB03, metaproterenol, The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Droperidol.]
[G02CB04, quinagolide, The therapeutic efficacy of Quinagolide can be decreased when used in combination with Droperidol.]
[G04CA02, tamsulosin, Droperidol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tamsulosin.]
[N05BA04, oxazepam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Oxazepam.]
[J01MB05, oxolinic acid, The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Droperidol.]
[C07AA02, oxprenolol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Oxprenolol.]
[N02AA05, oxycodone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Oxycodone.]
[C01DX03, oxyfedrine, The therapeutic efficacy of Oxyfedrine can be decreased when used in combination with Droperidol.]
[S01GA04, oxymetazoline, The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Droperidol.]
[N02AA11, oxymorphone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Oxymorphone.]
[N05AE01, oxypertine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Oxypertine.]
[S01BC02, oxyphenbutazone, The risk or severity of hypertension can be increased when Droperidol is combined with Oxyphenbutazone.]
[A03AB03, oxyphenonium, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.]
[H01BB02, oxytocin, The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Droperidol.]
[N05AH05, asenapine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Asenapine.]
[N02AX06, tapentadol, Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Droperidol.]
[M03AC01, pancuronium, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pancuronium.]
[G04BE02, papaverine, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Papaverine.]
[N05CC05, paraldehyde, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.]
[C02KC01, pargyline, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pargyline.]
[J01MA03, pefloxacin, The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Droperidol.]
[G04BD11, fesoterodine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.]
[C07AA23, penbutolol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Penbutolol.]
[N05AG03, penfluridol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Penfluridol.]
[N02AD01, pentazocine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pentazocine.]
[N05CA01, pentobarbital, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pentobarbital.]
[N05AB10, perazine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Perazine.]
[N04BC02, pergolide, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pergolide.]
[C08EX02, perhexiline, The risk or severity of hypotension can be increased when Droperidol is combined with Perhexiline.]
[N05AB03, perphenazine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Perphenazine.]
[N02AD02, phenazocine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Phenazocine.]
[N06AF03, phenelzine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Phenelzine.]
[R06AB05, pheniramine, The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Droperidol.]
[N03AA02, phenobarbital, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Phenobarbital.]
[N01AH04, phenoperidine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Phenoperidine.]
[C04AX02, phenoxybenzamine, Droperidol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Phenoxybenzamine.]
[A08AA01, phentermine, The therapeutic efficacy of Droperidol can be decreased when used in combination with Phentermine.]
[V03AB36, phentolamine, Droperidol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Phentolamine.]
[M02AA01, phenylbutazone, The risk or severity of hypertension can be increased when Droperidol is combined with Phenylbutazone.]
[S01GA05, phenylephrine, The therapeutic efficacy of Phenylephrine can be decreased when used in combination with Droperidol.]
[R01BA01, phenylpropanolamine, The therapeutic efficacy of Phenylpropanolamine can be decreased when used in combination with Droperidol.]
[N03AB02, phenytoin, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Phenytoin.]
[S01AE05, levofloxacin, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Levofloxacin.]
[C08CX01, mibefradil, The risk or severity of hypotension can be increased when Droperidol is combined with Mibefradil.]
[N05AG02, pimozide, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pimozide.]
[C07AA03, pindolol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pindolol.]
[J05AE01, saquinavir, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Saquinavir.]
[N05AC04, pipothiazine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pipotiazine.]
[C09CA02, eprosartan, Droperidol may decrease the antihypertensive activities of Eprosartan.]
[A02BX03, pirenzepine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pirenzepine.]
[N04BC08, piribedil, The therapeutic efficacy of Piribedil can be decreased when used in combination with Droperidol.]
[N02AC03, pirinitramide, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Piritramide.]
[S01BC06, piroxicam, The risk or severity of hypertension can be increased when Droperidol is combined with Piroxicam.]
[J01MA11, grepafloxacin, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Grepafloxacin.]
[N02CX01, pizotyline, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pizotifen.]
[C09CA04, irbesartan, Droperidol may decrease the antihypertensive activities of Irbesartan.]
[N05CA22, proxibarbal, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Proxibarbal.]
[A03AE01, alosetron, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Alosetron.]
[S03AA03, polymyxin B, Droperidol may increase the neurotoxic activities of Polymyxin B.]
[C03AA05, polythiazide, Droperidol may decrease the antihypertensive activities of Polythiazide.]
[J05AE03, ritonavir, The risk or severity of QTc prolongation can be increased when Ritonavir is combined with Droperidol.]
[C07AB01, practolol, Practolol may increase the orthostatic hypotensive activities of Droperidol.]
[C01BA08, prajmaline, The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Droperidol.]
[N05BA11, prazepam, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Prazepam.]
[C02CA01, prazosin, Droperidol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Prazosin.]
[R06AX05, antazoline, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Antazoline.]
[C01DX02, prenylamine, The risk or severity of hypotension can be increased when Droperidol is combined with Prenylamine.]
[N01BB04, prilocaine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Prilocaine.]
[P01BA03, primaquine, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Primaquine.]
[N03AA03, primidone, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Primidone.]
[C10AX02, probucol, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Probucol.]
[C01BA02, procainamide, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Procainamide.]
[S01HA05, procaine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Procaine.]
[L01XB01, procarbazine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Procarbazine.]
[N05AB04, prochlorperazine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Prochlorperazine.]
[N04AA04, procyclidine, The therapeutic efficacy of Procyclidine can be decreased when used in combination with Droperidol.]
[N05AA03, promazine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Promazine.]
[R06AD02, promethazine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Promethazine.]
[C01BC03, propafenone, Propafenone may increase the orthostatic hypotensive activities of Droperidol.]
[N01AX04, propanidid, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Propanidid.]
[A03AB05, propantheline, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Propantheline.]
[N05AC01, periciazine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Periciazine.]
[N05CM06, propiomazine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Propiomazine.]
[L01XH02, romidepsin, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Romidepsin.]
[N01AX10, propofol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Propofol.]
[N02AC04, propoxyphene, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dextropropoxyphene.]
[C07AA05, propranolol, Propranolol may increase the orthostatic hypotensive activities of Droperidol.]
[N02CC04, rizatriptan, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Rizatriptan.]
[B01AC09, epoprostenol, Droperidol may decrease the antihypertensive activities of Epoprostenol.]
[N06AA11, protriptyline, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Protriptyline.]
[R01BA02, pseudoephedrine, The therapeutic efficacy of Droperidol can be decreased when used in combination with Pseudoephedrine.]
[N05AX12, aripiprazole, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Aripiprazole.]
[A03AB15, diphemanil, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Diphemanil.]
[A03AB09, isopropamide, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.]
[S01FA03, methscopolamine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Methscopolamine.]
[N05CA07, talbutal, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Talbutal.]
[N05CA09, vinbarbital, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Vinbarbital.]
[N05BB02, captodiamine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Captodiame.]
[M03BA04, styramate, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Styramate.]
[P02CC01, pyrantel, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pyrantel.]
[R06AC01, pyrilamine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Mepyramine.]
[C01BA01, quinidine, Droperidol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.]
[P01BC01, quinine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Quinine.]
[C02AA01, rescinnamine, Droperidol may decrease the antihypertensive activities of Rescinnamine.]
[C02AA02, reserpine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Reserpine.]
[R03AC05, rimiterol, The therapeutic efficacy of Rimiterol can be decreased when used in combination with Droperidol.]
[G02CA01, ritodrine, The therapeutic efficacy of Ritodrine can be decreased when used in combination with Droperidol.]
[N06AX01, 5-hydroxytryptophan, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Oxitriptan.]
[J01FA06, roxithromycin, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Roxithromycin.]
[N02BA05, salicylamide, The risk or severity of hypertension can be increased when Droperidol is combined with Salicylamide.]
[A07EC01, sulfasalazine, The risk or severity of hypertension can be increased when Droperidol is combined with Sulfasalazine.]
[S01BC08, salicylic acid, The risk or severity of hypertension can be increased when Droperidol is combined with Salicylic acid.]
[S01FA02, scopolamine, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Scopolamine.]
[N05CA06, secobarbital, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Secobarbital.]
[N04BD01, selegiline, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Selegiline.]
[C07AA07, sotalol, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Sotalol.]
[N05CC01, chloral hydrate, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Chloral hydrate.]
[N03AG01, valproic acid, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Valproic acid.]
[R03BB01, ipratropium bromide, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ipratropium.]
[N05AL01, sulpiride, QT prolonging agents - QT prolonging agents]
[N05AC02, thioridazine, QT prolonging agents - QT prolonging agents]
[L01EX04, vandetanib, QT prolonging agents - QT prolonging agents]
[N06DA02, donepezil, QT prolonging agents - QT prolonging agents]
[S01AE07, moxifloxacin, QT prolonging agents - QT prolonging agents]
[C08EA02, bepridil, QT prolonging agents - QT prolonging agents]
[L01XX27, arsenic trioxide, QT prolonging agents - QT prolonging agents]
[J01MA09, sparfloxacin, QT prolonging agents - QT prolonging agents]
[S01AA26, azithromycin, QT prolonging agents - QT prolonging agents]
[B01AC23, cilostazol, QT prolonging agents - QT prolonging agents]
[J01FA09, clarithromycin, QT prolonging agents - QT prolonging agents]
[S01AE06, gatifloxacin, QT prolonging agents - QT prolonging agents]
[C01BD07, dronedarone, QT prolonging agents - QT prolonging agents]
[L01DB04, aclarubicin, QT prolonging agents - QT prolonging agents]
[P01BA01, chloroquine, QT prolonging agents - QT prolonging agents]
[N05AA01, chlorpromazine, QT prolonging agents - QT prolonging agents]
[N05AF03, chlorprothixene, QT prolonging agents - QT prolonging agents]
[S03AA07, ciprofloxacin, QT prolonging agents - QT prolonging agents]
[N06AB04, citalopram, QT prolonging agents - QT prolonging agents]
[L01EB10, mobocertinib, QT prolonging agents - QT prolonging agents]
[A04AA01, ondansetron, QT prolonging agents - QT prolonging agents]
[S02DA02, cocaine, QT prolonging agents - QT prolonging agents]
[C01BA13, hydroquinidine, QT prolonging agents - QT prolonging agents]
[P01CB01, meglumine antimoniate, QT prolonging agents - QT prolonging agents]
[L01XA03, oxaliplatin, QT prolonging agents - QT prolonging agents]
[A03FA02, cisapride, QT prolonging agents - QT prolonging agents]
[C01BA03, disopyramide, QT prolonging agents - QT prolonging agents]
[A03FA03, domperidone, QT prolonging agents - QT prolonging agents]
[N01AB08, sevoflurane, QT prolonging agents - QT prolonging agents]
[N05AL02, sultopride, QT prolonging agents - QT prolonging agents]
[G04BD05, terodiline, QT prolonging agents - QT prolonging agents]
[S01AA17, erythromycin, QT prolonging agents - QT prolonging agents]
[C01BD05, ibutilide, QT prolonging agents - QT prolonging agents]
[N05AE03, sertindole, QT prolonging agents - QT prolonging agents]
[R06AX11, astemizole, QT prolonging agents - QT prolonging agents]
[R06AX12, terfenadine, QT prolonging agents - QT prolonging agents]
[C01BC04, flecainide, QT prolonging agents - QT prolonging agents]
[J02AC01, fluconazole, QT prolonging agents - QT prolonging agents]
[C01BD04, dofetilide, QT prolonging agents - QT prolonging agents]
[P01BX01, halofantrine, QT prolonging agents - QT prolonging agents]
[N05AD01, haloperidol, QT prolonging agents - QT prolonging agents]
[P01BA02, hydroxychloroquine, QT prolonging agents - QT prolonging agents]
[H01BA04, terlipressin, QT prolonging agents - QT prolonging agents]
[L01XX35, anagrelide, QT prolonging agents - QT prolonging agents]
[N05AC03, mesoridazine, QT prolonging agents - QT prolonging agents]
[N07BC02, methadone, QT prolonging agents - QT prolonging agents]
[N05AA02, methotrimeprazine, QT prolonging agents - QT prolonging agents]
[C01BD01, amiodarone, QT prolonging agents - QT prolonging agents]
[S01AE05, levofloxacin, QT prolonging agents - QT prolonging agents]
[N05AG02, pimozide, QT prolonging agents - QT prolonging agents]
[J01MA11, grepafloxacin, QT prolonging agents - QT prolonging agents]
[C10AX02, probucol, QT prolonging agents - QT prolonging agents]
[C01BA02, procainamide, QT prolonging agents - QT prolonging agents]
[N01AX10, propofol, QT prolonging agents - QT prolonging agents]
[C01BA01, quinidine, QT prolonging agents - QT prolonging agents]
[J01FA06, roxithromycin, QT prolonging agents - QT prolonging agents]
[C07AA07, sotalol, QT prolonging agents - QT prolonging agents]
